ANI Pharmaceuticals develops, makes, and sells prescription medicines, including rare disease, brand name, and generic drugs. It last closed at $69.99 on Nov 17, down 1.27% on the day. ANIP last reported earnings on Fri, Aug 7, 2026. The average 12-month price target from 2 analysts is $103.00 (+47.2% from the last close), with a high of $121.00 and a low of $85.00.
Only 2 firms rated ANIP in the past 90 days, not enough for a consensus
Average 12-month target
$103.00
▲ 47.2% upside
Based on 2 analysts who set a price target on ANIP in the past 90 days. The average target is $103.00, with a high of $121.00 and a low of $85.00, compared with the last close of $69.99.
Low $85.00Avg $103.00High $121.00
Blue marker: last close $69.99
Highest target$121.00
Average target$103.00
Lowest target$85.00
Latest rating changes
GuggenheimTarget raised
Nov 6Buy$119 → $121
OppenheimerInitiated
Sep 23Buy$85
GuggenheimMaintained
Aug 10Buy$119
Canaccord GenuityTarget lowered
Aug 10Hold$91 → $90
Canaccord GenuityInitiated
Jul 17Hold$91
Date
Firm
Action
Rating
Price target
Nov 6
Guggenheim
Target raised
Buy
$119 → $121
Sep 23
Oppenheimer
Initiated
Buy
$85
Aug 10
Guggenheim
Maintained
Buy
$119
Aug 10
Canaccord Genuity
Target lowered
Hold
$91 → $90
Jul 17
Canaccord Genuity
Initiated
Hold
$91
Loading…
Technical Analysis
ANIP · as of the Nov 17 close · updated after every close
Downtrend
The stock is 2% below its 20 day and 3% below its 50 day average. It is 10% below its 200 day average, so the longer trend is down. Momentum is neutral (RSI 45). The nearest support is the swing low (Oct 14) at $69.90, and the nearest resistance the Pivot at $70.19.
Short trendBearish
Long trendBearish
MomentumNeutral
StretchNormal
VolatilityHigh, 3.3%/day
Key levels
$87.7652 week high+25.4%
$76.90200 day average+9.9%
$75.31100 day average+7.6%
$72.3050 day average+3.3%
$72.20Swing high (Nov 11)+3.2%
$71.2220 day average+1.8%
$70.73Pivot R1+1.1%
$70.19Pivot+0.3%
$69.99Last close
$69.90Swing low (Oct 14)−0.1%
$69.46Pivot S1−0.8%
$67.1452 week low−4.1%
Indicators
RSI (14)
44.73
Middle of its range
Neutral
MACD
-0.59
Above its signal line
Bullish
Stochastic
41.0
Middle of its range
Neutral
ADX (14)
10.3
No clear trend
Williams %R
-67.9
Oversold below −80, overbought above −20
Neutral
CCI (20)
-78.4
Oversold below −100, overbought above 100
Neutral
Rate of change
−3.2%
Change over 10 sessions
Bearish
ATR (14)
$2.28
Typical daily range, 3.3% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Falling
Short trendBearish
Long trendNot enough history
MomentumWeak
StretchNormal
VolatilityNormal, 6.8%/day
Key levels
$87.7652 week high+25.4%
$76.90200 day average+9.9%
$75.31100 day average+7.6%
$72.3050 day average+3.3%
$72.20Swing high (Nov 11)+3.2%
$71.2220 day average+1.8%
$70.73Pivot R1+1.1%
$70.19Pivot+0.3%
$69.99Last close
$69.90Swing low (Oct 14)−0.1%
$69.46Pivot S1−0.8%
$67.1452 week low−4.1%
Indicators
RSI (14)
42.25
Middle of its range
Neutral
MACD
-2.29
Below its signal line
Bearish
Stochastic
19.9
Near the bottom of its range
Oversold
ADX (14)
15.5
No clear trend
Williams %R
-76.8
Oversold below −80, overbought above −20
Neutral
CCI (20)
-89.7
Oversold below −100, overbought above 100
Neutral
Rate of change
−0.3%
Change over 10 sessions
Bearish
ATR (14)
$4.79
Typical daily range, 6.8% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200–
What happened before, for ANIP
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how ANIP did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow ANIP usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How ANIP has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ANIP is in one of them and how their past ANIP trades turned out.
ANI Pharmaceuticals is a biopharmaceutical company based in Princeton, New Jersey. It develops, manufactures, and sells prescription medicines in three areas: rare disease treatments, brand name products, and generic drugs. Its rare disease products include Purified Cortrophin Gel and the ILUVIEN and YUTIQ eye implants, which treat conditions such as diabetic macular edema and uveitis. The company makes its products at its own plants in Minnesota and New Jersey and sells them to patients, physicians, and specialty pharmacies.